Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals - Scorecard - MDSpire

Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals

  • By

  • Noha M. Amin

  • Amira R. Ismail

  • Shimaa M. Abdel Aal

  • Aly ELkazaz

  • Hala Ramadan

  • Ahmed Mohamed Shenawy

  • Shaimaa Mohamed Ali

  • Shimaa Saad El-Din

  • Magda SA Abdeltawab

  • April 1, 2026

  • 0 min

Share

Clinical Scorecard: Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals

At a Glance

CategoryDetail
Condition
Key MechanismsIntestinal inflammation mediated by pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-1β, IL-8) and immune response activation.
Target Population
Care Setting

Key Highlights

  • Different subtypes of Blastocystis spp. exhibit varying inflammatory effects on the gut.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of Blastocystis spp. infection via microscopic examination and stool culture on Jones’ medium.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with gastrointestinal symptoms confirmed to have Blastocystis spp. infection.

        Efficacy of metronidazole varies among different Blastocystis subtypes.

        Clinical Best Practices

        • Monitor specific inflammatory markers such as fecal calprotectin pre- and post-treatment.

        References

        Original Source(s)

        Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals

        • by Noha M. Amin, Amira R. Ismail, Shimaa M. Abdel Aal, Aly ELkazaz, Hala Ramadan, Ahmed Mohamed Shenawy, Shaimaa Mohamed Ali, Shimaa Saad El-Din, Magda SA Abdeltawab

        • April 1, 2026

        Related Content

        Refining Vancomycin Use in Early CDI

        A modified dosing approach could reshape recurrence prevention strategies.

        Melatonin-induced restoration of the intestinal mucosal barrier in inflammatory bowel disease via activation of the SIRT1-LKB1-pAMPK axis

        Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management